# LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE
> **NDA205626** · New Drug Application · Sponsor: MICRO LABS · Approved 2018-08-13
## Drug
- **FDA Application Number:** NDA205626
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** MICRO LABS
- **First approval:** 2018-08-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205626)
---
*MORVS · CC0 1.0*